Boardroom Alpha
Boardroom Alpha
AMBA · Current Report (Form 8-K) · Filed June 6, 2025

Ambarella Inc — Current Report (Form 8-K)

Form
8-K
Filed
June 6, 2025
Period
Jun 4, 2025
Ticker
AMBA
Accession
0001193125-25-137166
Boardroom Alpha · Filing insights

Three Class I directors elected; PwC retained as auditor; executive compensation advisory vote approved.

About Ambarella Inc
Market cap
$3.4B
1Y TSR
+42.0%
3Y TSR
−0.6%
Board grade
C
Sector
Technology
CEO
Feng-Ming Wang
Last annual meeting: Jun 26, 2026 · View full Ambarella Inc profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

June 4, 2025

Date of Report (date of earliest event reported)

 

 

AMBARELLA, INC.

(Exact name of Registrant as specified in its charter)

 

 

 

Cayman Islands   001-35667   98-0459628

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I. R. S. Employer

Identification No.)

3101 Jay Street

Santa Clara, CA 95054

(Address of principal executive offices)

Registrant’s telephone number, including area code: (408) 734-8888

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Ordinary Shares, $0.00045 par value   AMBA   The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 5.07

Submission of Matters to a Vote of Security Holders.

On June 4, 2025, Ambarella, Inc. (the “Company”) held its 2025 Annual Meeting of Shareholders. Of the 42,413,308 ordinary shares outstanding as of April 15, 2025, the record date for the meeting, 36,074,054 ordinary shares were represented at the meeting in person or by proxy, constituting approximately 85.05% of the outstanding ordinary shares entitled to vote at the meeting. The matters voted upon at the meeting and the voting results with respect to each such matter are set forth below:

 

  (i)

Election of three Class I Directors

Each of the following nominees was elected to serve as a Class I director, to hold office until the Company’s 2028 annual meeting of shareholders or until his or her respective successor has been duly elected and qualified.

 

Name

   For      Withheld  

Chantelle Breithaupt

     29,233,346        149,056  

Chenming Hu, Ph.D.

     26,882,040        2,500,362  

Feng-Ming (Fermi) Wang, Ph.D.

     27,811,742        1,570,660  

There were 6,691,652 broker non-votes with respect to the election of each of the above nominees.

 

  (ii)

Ratification of Appointment of Independent Registered Public Accounting Firm

The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 31, 2026 was ratified based on the following results of voting:

 

For: 35,740,912

  Against: 256,544   Abstentions: 76,598

 

  (iii)

Advisory Vote to Approve Executive Compensation

The Company’s shareholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s proxy statement, based on the following results of voting:

 

For: 27,294,574

  Against: 2,004,585   Abstentions: 83,243

There were 6,691,652 broker non-votes with respect to this proposal.


Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: June 6, 2025     Ambarella, Inc.
   

/s/ Michael Morehead

   

Michael Morehead

General Counsel and Corporate Secretary

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Ambarella Inc (AMBA)

Reference

Frequently asked questions

When did Ambarella Inc file this 8-K?
Ambarella Inc (AMBA) filed this Current Report (Form 8-K) with the SEC on June 6, 2025. The accession number assigned by EDGAR is 0001193125-25-137166.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Three Class I directors elected; PwC retained as auditor; executive compensation advisory vote approved. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Ambarella Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Ambarella Inc has filed under CIK 1280263, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer